HOME >> BIOLOGY >> NEWS
Budding viral hijackers may co-opt cell machinery for the getaway

When retroviruses like HIV infect cells, they take over the cell's machinery to manufacture new copies of themselves. Research published this week in the top-tier open access journal, Journal of Biology, shows that to escape from cells, retroviruses may once again hijack cellular components, in this case molecules normally used to engulf material from the cell's surroundings in a pocket formed from cell membrane. The findings, offer new insights into how viruses propagate and cause disease, and how healthy cells work.

Retroviruses travel from cell to cell in 'spacecraft' surrounded by the membrane of host cells. These transporters protect the virus from attack by the immune system, as they disguise the virus as part of the body. The outer membrane of the virus particle also helps the virus to spread, as it can fuse with the membrane of other vulnerable cells.

During the construction of a virus particle, or virion, the cell membrane bulges outwards, engulfing viral components as it goes. One of the viral proteins, called Gag, is essential for this process.

Now, researchers from Columbia and Yale Universities, USA, Aijou University, South Korea and the Chinese Academy of Sciences has shown that some retroviral Gag proteins bind tightly to a host-cell protein called endophilin-2. Endophilin-2 is normally involved in the inward budding of the cell membrane, a process known as endocytosis.

Supporting the idea that this interaction is functionally relevant, the researchers found endophilin-2 inside viral particles that had budded from cells infected with Moloney-murine leukaemia virus. On further examination, they also found two other proteins involved in endocytosis, a-adaptin and clathrin, inside the virions. However, Dynamin-2, a protein that binds to endophilin-2, was not there. This suggests that the incorporation of selected proteins is unlikely to be accidental.

Endophilin-2's normal role is to increase the curvature of the
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-0-20-7323-0323
BioMed Central
3-Dec-2003


Page: 1 2

Related biology news :

1. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
2. First glimpse of DNA binding to viral enzyme
3. X marks the spot: Vector insertion is viral specific
4. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
5. Researchers develop better understanding of immune response to viral infection
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Sick Kids researchers look at viral triggers for multiple sclerosis in children
8. The catch 22 of immune response to AIDs viral infection
9. A viral cure for type 1 diabetes
10. Purdue biologists expose the inner workings of viral machine
11. Retroviral protein triggers proliferation of immune cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... management solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal ... most inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 ...
(Date:8/1/2018)... ... July 31, 2018 , ... ... Awards at Global Conference , Awards honor late founder of Wisdom National Brands® ... National Brands, presented prestigious stevia awards to a renowned German professor and a ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is now ... The treatments are offered by Double Board Certified providers, with outcomes significantly improving patient ... suppressing symptoms, but have done nothing to help repair and regenerate damaged lung tissues. ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/13/2017)... KING OF PRUSSIA, PA (PRWEB) , ... October 13, 2017 , ... ... Group Vice President and Turesol Business Unit Leader, will moderate a discussion on the ... this year’s ISPE Annual Meeting & Expo . The theme of this year’s ...
Breaking Biology Technology:
Cached News: